IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cytomx Therapeutics Inc.

CUSIP: 23284F106 | 1 institutional holders

Quarters

Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Seven Fleet Capital Management LP714,000
1.1% of portfolio›$3.4M
StyleTurnoverLocationFiled
Seven Fleet Capital Management LP
714,000$3.4M1.1%GrowthVery HighMountain View, CA2026-06-04